Literature DB >> 28921110

Detection of acetazolamide-induced increase in organ blood flow in rabbits by laser flowmetry.

Kenji Taki1, Ichirou Nagasawa2, Kenji Hirahara1, Shinji Tomita1, Nobuo Baba1, Tadahide Totoki2.   

Abstract

PURPOSE: We investigated the mechanism by which inhibition of carbonic anhydrase (CA) increases organ blood flow.
METHODS: Regional blood flow (rBF) in white rabbits anesthetized with ketamine/urethane was measured in the kidney, liver, stomach wall, and abdominal muscle by means of laser blood flow probes. Data obtained from rabbits receiving acetazolamide (AZ) to inhibit CA were compared with those obtained from rabbits ventilated with air containing increased concentrations of CO2.
RESULTS: Systolic blood pressure, body temperature, hemoglobin, and base excess were unaffected by either treatment. Inhalation of CO2 increased blood flow in all organs tested as well as the cardiac output and PCO2 but decreased pH. Inhibition of CA by AZ administration increased the rBF only in the liver and kidney and did not increase cardiac output or decrease pH.
CONCLUSION: Administration of AZ increased rBF in the tissues and organs that contained large amounts of CA without increasing the cardiac output or decreasing the pH, which suggests a direct local effect. A differential sensitivity to the retention of CO2 is suggested as a possible mechanism of the selectivity of the increase in rBF.

Entities:  

Keywords:  Acetazolamide; Carbonic anhydrase; Carbonic anhydrase inhibitor; Laser flowmeter; Organ blood flow

Year:  1997        PMID: 28921110     DOI: 10.1007/BF02480036

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  23 in total

1.  Disturbance of CO2 elimination in the lungs by carbonic anhydrase inhibition.

Authors:  K Taki; K Mizuno; N Takahashi; R Wakusawa
Journal:  Jpn J Physiol       Date:  1986

2.  Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide.

Authors:  E B Ringelstein; S Van Eyck; I Mertens
Journal:  J Cereb Blood Flow Metab       Date:  1992-01       Impact factor: 6.200

3.  Near infrared optical monitoring of cat skeletal muscle during hypercapnia.

Authors:  N B Hampson; C A Piantadosi; F F Jöbsis-VanderVliet
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

4.  The effect of acidosis on the relationship between Ca2+ and force in isolated ferret cardiac muscle.

Authors:  C H Orchard; D L Hamilton; P Astles; E McCall; B R Jewell
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

5.  Effect of acetazolamide on cerebral blood flow velocity and CO2 elimination in normotensive and hypotensive newborn piglets.

Authors:  M Thoresen; A Whitelaw
Journal:  Biol Neonate       Date:  1990

6.  Continuous monitoring of gastroduodenal mucosal hemodynamics in rats by laser-Doppler flowmetry and reflectance spectrophotometry.

Authors:  T Yamaguchi
Journal:  Gastroenterol Jpn       Date:  1989-12

7.  [Effects of acidosis on the neuronal function following oxygen-glucose deprivation in the rat hippocampal slices].

Authors:  Y Morimoto
Journal:  Hokkaido Igaku Zasshi       Date:  1993-09

8.  Effects of acetazolamide on cerebrocortical NADH and blood volume.

Authors:  P E Bickler; L Litt; J W Severinghaus
Journal:  J Appl Physiol (1985)       Date:  1988-07

9.  [Effects of carbon dioxide (hypocapnia and hypercapnia) on tissue blood flow and oxygenation of liver, kidney and skeletal muscle in the dog].

Authors:  K Okazaki; Y Okutsu; A Fukunaga
Journal:  Masui       Date:  1989-04

10.  Isosorbide dinitrate blocks thromboxane synthesis caused by CO2 in dog heart-lung preparation.

Authors:  N Ishikawa; I Ichimura; M Kainuma; T Shigei
Journal:  Jpn J Pharmacol       Date:  1987-10
View more
  1 in total

1.  Acetazolamide-induced increase in blood flow to rabbit organs is confirmed using colored microspheres.

Authors:  K Taki; K Hirahara; S Tomita; T Totoki
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.